A detailed history of Bml Capital Management, LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 3,457,395 shares of RPHM stock, worth $5.81 Million. This represents 3.46% of its overall portfolio holdings.

Number of Shares
3,457,395
Previous 2,672,194 29.38%
Holding current value
$5.81 Million
Previous $4.04 Billion 45.66%
% of portfolio
3.46%
Previous 2.88%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$1.34 - $1.7 $1.05 Million - $1.33 Million
785,201 Added 29.38%
3,457,395 $5.88 Billion
Q2 2024

Aug 07, 2024

BUY
$1.51 - $1.9 $746,364 - $939,133
494,281 Added 22.7%
2,672,194 $4.04 Billion
Q1 2024

Apr 23, 2024

BUY
$1.59 - $1.74 $1.37 Million - $1.5 Million
863,684 Added 65.72%
2,177,913 $3.62 Billion
Q4 2023

Jan 30, 2024

BUY
$1.34 - $8.43 $1.76 Million - $11.1 Million
1,314,229 New
1,314,229 $2.1 Billion

Others Institutions Holding RPHM

About Reneo Pharmaceuticals, Inc.


  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.